SynBioBeta Speaker
Daniel Goodman
Postdoctoral Fellow, UCSF
UCSF
A synthetic immunologist and computational biologist working at the intersection of genome engineering, immune cell therapy, and genetic design using generative models. Working at UCSF with Kole Roybal & Alex Marson on the next generation of T cell therapies for cancer and autoimmune disease. MIT Ph. D. alum from George Church's lab.
SynBioBeta 2025 - Session Speaker
Designing Cellular Medicines: Using High-Throughput Experiments and AI Approaches to Program Cells to Cure Disease
We now live in a world where genetically engineered cells are circulating people's bodies and warding off cancer. But the first approved cell-based medicines—such as CAR-T therapy—are just the beginning. In this session, we'll explore the next generation of programmable cellular medicines.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Conference Pass
1,995
USD
Save $1,000
Regular Rate
$2,995
Access to all 120+ Sessions
Attendee Directory
Networking Reception
1:1 Partnering App
1:1 Meeting Space
Meals & Refreshments
Post Event Video Access
Price increases in
09:11:42:52
Purchase Pass
Purchase Pass
Cyber Week Deal
Buy 1 Conference Pass, Get 1 Expo Pass Free
Previous Speakers Include
2026
Event Updates